REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208 | -10.3% | 18,103 | +97.6% | 0.00% | 0.0% |
| Q2 2023 | $232 | -20.5% | 9,161 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $292 | +42.4% | 9,061 | -18.3% | 0.00% | 0.0% |
| Q4 2022 | $205 | -99.9% | 11,095 | +2.7% | 0.00% | -50.0% |
| Q3 2022 | $292,000 | +97.3% | 10,806 | +0.7% | 0.00% | +100.0% |
| Q2 2022 | $148,000 | -40.3% | 10,735 | -15.7% | 0.00% | 0.0% |
| Q1 2022 | $248,000 | -25.7% | 12,731 | -37.8% | 0.00% | -50.0% |
| Q4 2021 | $334,000 | -49.1% | 20,464 | -13.1% | 0.00% | -60.0% |
| Q3 2021 | $656,000 | -6.0% | 23,551 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $698,000 | -11.6% | 23,551 | -16.6% | 0.01% | -28.6% |
| Q1 2021 | $790,000 | -9.7% | 28,252 | -8.5% | 0.01% | -36.4% |
| Q4 2020 | $875,000 | – | 30,869 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |